DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award is offered by Defense Health Agency Contracting Activity - DHACA. Max award: Not specified. Applications close on Oct 22, 2026.
| Opportunity number | HT942526TBDRPTDRA |
|---|---|
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Posted |
| Posted | May 5, 2026 |
| Closes | Oct 22, 2026 |
| Award ceiling | Not specified |
| Award floor | Not specified |
| Total program funding | $2,650,000 |
| Expected awards | 2 |
| Who can apply | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Category | Science and Technology and other Research and Development |
Summary (excerpt)
Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to adva…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from Defense Health Agency Contracting Activity - DHACA